Search Results for "Harvoni"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Harvoni. Results 1 to 3 of 3 total matches.
See also: ledipasvir, sofosbuvir
Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults (online only)
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
/sofosbuvir = Harvoni*
Elbasvir/grazoprevir = Zepatier
Sofosbuvir/velpatasvir/voxilaprevir = Vosevi
*Also ...
View Figure 1: Treatment of Hepatitis C Virus Infection in Treatment-Naive Adults
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e174 doi:10.58347/tml.2024.1714e | Show Introduction Hide Introduction
Drugs for Hepatitis C Virus Infection
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
or
Sofosbuvir/velpatasvir (Epclusa)* x 12 weeks or
Ledipasvir/sofosbuvir (Harvoni)* x 12 weeks1 or
Elbasvir ...
About 2.5 million persons in the US had hepatitis C
between 2017 and 2020. Guidelines from the American
Association for the Study of Liver Diseases (AASLD)
and the Infectious Diseases Society of America (IDSA)
on management of hepatitis C virus (HCV) infection
were updated in 2023.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):169-74 doi:10.58347/tml.2024.1714a | Show Introduction Hide Introduction
Table 3: Some Drug Interactions with DAAs for HCV Infection (online only)
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
for dabigatran
Ledipasvir/sofosbuvir (Harvoni, and authorized generic)
P-gp inducers2 Decreased DAA serum ...
View Table 3: Some Drug Interactions with DAAs for HCV Infection
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e175 doi:10.58347/tml.2024.1714f | Show Introduction Hide Introduction